Overview

Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects

Status:
Completed
Trial end date:
2022-01-12
Target enrollment:
Participant gender:
Summary
Skin Irritation and Phototoxicity Study of KX01 Ointment 1% in Japanese healthy male subjects
Phase:
Phase 1
Details
Lead Sponsor:
PharmaEssentia
Collaborator:
PharmaEssentia Japan K.K.